Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Metabolon is the global leader in metabolomics services, providing comprehensive small molecule profiling and actionable insights for biopharma, healthcare, population health, consumer products, agriculture, wellness sectors as well as academic/government research. Their platforms enable biomarker discovery and support multiomic studies across more than 70 metabolic pathways with over 5,400 metabolites identified per sample. They have completed over 10,000 projects globally with data cited in more than 3,500 publications. Their technology supports all phases of biomedical research but they do not themselves develop therapeutic drugs or diagnostics for regulatory approval.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Metabolon.